Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Marc P. Bonaca, Andrei‐Mircea Catarig, Kim Christian Houlind, Bernhard Ludvik, Joakim Nordanstig, Chethana Ramesh, Neda Rasouli, Harald Sourij, Alex N. Videmark, Subodh Verma
Topics & Concepts
SemaglutideMedicineType 2 diabetesPlaceboSTRIDEArterial diseaseDiabetes mellitusPhysical therapyPeripheralInternal medicineDouble blindRandomized controlled trialPhysical medicine and rehabilitationCardiologyVascular diseaseEndocrinologyAlternative medicinePathologyLiraglutidePeripheral Artery Disease ManagementDiagnosis and Treatment of Venous DiseasesDiabetes Treatment and Management